Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

BACKGROUND: The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li Bassi, Gianluigi, Gibbons, Kristen, Suen, Jacky Y., Dalton, Heidi J., White, Nicole, Corley, Amanda, Shrapnel, Sally, Hinton, Samuel, Forsyth, Simon, Laffey, John G., Fan, Eddy, Fanning, Jonathon P., Panigada, Mauro, Bartlett, Robert, Brodie, Daniel, Burrell, Aidan, Chiumello, Davide, Elhazmi, Alyaa, Esperatti, Mariano, Grasselli, Giacomo, Hodgson, Carol, Ichiba, Shingo, Luna, Carlos, Marwali, Eva, Merson, Laura, Murthy, Srinivas, Nichol, Alistair, Ogino, Mark, Pelosi, Paolo, Torres, Antoni, Ng, Pauline Yeung, Fraser, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112652/
https://www.ncbi.nlm.nih.gov/pubmed/35581612
http://dx.doi.org/10.1186/s13054-022-03983-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112652/
https://www.ncbi.nlm.nih.gov/pubmed/35581612
http://dx.doi.org/10.1186/s13054-022-03983-5

Ejemplares similares